Medicenna Net Interest Income from 2010 to 2026
| MDNA Stock | CAD 0.92 0.02 2.22% |
Net Interest Income | First Reported 2019-03-31 | Previous Quarter 204 K | Current Value 158 K | Quarterly Volatility 147.4 K |
Check Medicenna Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Medicenna Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 62.5 K, Interest Expense of 14 M or Selling General Administrative of 4.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 3.72. Medicenna financial statements analysis is a perfect complement when working with Medicenna Therapeutics Valuation or Volatility modules.
Medicenna | Net Interest Income |
Latest Medicenna Therapeutics' Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Medicenna Therapeutics Corp over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Medicenna Therapeutics' Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Medicenna Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Medicenna Net Interest Income Regression Statistics
| Arithmetic Mean | 427,466 | |
| Geometric Mean | 65,429 | |
| Coefficient Of Variation | 145.22 | |
| Mean Deviation | 530,270 | |
| Median | 32,740 | |
| Standard Deviation | 620,746 | |
| Sample Variance | 385.3B | |
| Range | 1.6M | |
| R-Value | 0.82 | |
| Mean Square Error | 131.7B | |
| R-Squared | 0.68 | |
| Significance | 0.000047 | |
| Slope | 101,341 | |
| Total Sum of Squares | 6.2T |
Medicenna Net Interest Income History
About Medicenna Therapeutics Financial Statements
Medicenna Therapeutics investors utilize fundamental indicators, such as Net Interest Income, to predict how Medicenna Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 1.6 M | 1.6 M |
Other Information on Investing in Medicenna Stock
Medicenna Therapeutics financial ratios help investors to determine whether Medicenna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicenna with respect to the benefits of owning Medicenna Therapeutics security.